Last reviewed 2026-04-22 · How we verify

engineered HB vaccine

Southeast University, China · FDA-approved active Biologic

engineered HB vaccine is a Vaccine Biologic drug developed by Southeast University, China. It is currently FDA-approved for Prevention of hepatitis B virus infection. Also known as: control group.

An engineered hepatitis B vaccine that stimulates immune responses to prevent hepatitis B virus infection through enhanced antigen presentation.

An engineered hepatitis B vaccine that stimulates immune responses to prevent hepatitis B virus infection through enhanced antigen presentation. Used for Prevention of hepatitis B virus infection.

At a glance

Generic name	engineered HB vaccine
Also known as	control group
Sponsor	Southeast University, China
Drug class	Vaccine
Target	Hepatitis B surface antigen (HBsAg)
Modality	Biologic
Therapeutic area	Immunology / Infectious Disease
Phase	FDA-approved

Mechanism of action

This vaccine contains modified or recombinant hepatitis B surface antigen (HBsAg) designed to elicit stronger cellular and humoral immune responses compared to conventional HB vaccines. The engineering approach aims to improve immunogenicity and protective efficacy, potentially through optimization of antigen structure, formulation, or delivery to enhance B cell and T cell activation against hepatitis B virus.

Approved indications

Prevention of hepatitis B virus infection

Common side effects

Injection site pain or swelling
Fever
Fatigue
Myalgia

Key clinical trials

Efficacy and Safety Study of Telbivudine to Prevent Perinatal Transmission (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

engineered HB vaccine CI brief — competitive landscape report
engineered HB vaccine updates RSS · CI watch RSS
Southeast University, China portfolio CI

Frequently asked questions about engineered HB vaccine

What is engineered HB vaccine?

engineered HB vaccine is a Vaccine drug developed by Southeast University, China, indicated for Prevention of hepatitis B virus infection.

How does engineered HB vaccine work?

An engineered hepatitis B vaccine that stimulates immune responses to prevent hepatitis B virus infection through enhanced antigen presentation.

What is engineered HB vaccine used for?

engineered HB vaccine is indicated for Prevention of hepatitis B virus infection.

Who makes engineered HB vaccine?

engineered HB vaccine is developed and marketed by Southeast University, China (see full Southeast University, China pipeline at /company/southeast-university-china).

Is engineered HB vaccine also known as anything else?

engineered HB vaccine is also known as control group.

What drug class is engineered HB vaccine in?

engineered HB vaccine belongs to the Vaccine class. See all Vaccine drugs at /class/vaccine.

What development phase is engineered HB vaccine in?

engineered HB vaccine is FDA-approved (marketed).

What are the side effects of engineered HB vaccine?

Common side effects of engineered HB vaccine include Injection site pain or swelling, Fever, Fatigue, Myalgia.

What does engineered HB vaccine target?

engineered HB vaccine targets Hepatitis B surface antigen (HBsAg) and is a Vaccine.

Drug class: All Vaccine drugs
Target: All drugs targeting Hepatitis B surface antigen (HBsAg)
Manufacturer: Southeast University, China — full pipeline
Therapeutic area: All drugs in Immunology / Infectious Disease
Indication: Drugs for Prevention of hepatitis B virus infection
Also known as: control group

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing